Literature DB >> 12947201

Persistence without pathology in phosphoglycan-deficient Leishmania major.

Gerald F Späth1, Lon-Fey Lye, Hiroaki Segawa, David L Sacks, Salvatore J Turco, Stephen M Beverley.   

Abstract

Leishmania infections involve an acute phase of replication within macrophages, typically associated with pathology. After recovery parasites persist for long periods, which can lead to severe disease upon reactivation. Unlike the role of host factors, parasite factors affecting persistence are poorly understood. Leishmania major lacking phosphoglycans (lpg2-) were unable to survive in sand flies and macrophages, but retained the ability to persist indefinitely in the mammalian host without inducing disease. The L. major lpg2- thus provides a platform for probing parasite factors implicated in persistence and its role in disease and immunity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12947201     DOI: 10.1126/science.1087499

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  75 in total

1.  Probing elongating and branching β-D-galactosyltransferase activities in Leishmania parasites by making use of synthetic phosphoglycans.

Authors:  Olga V Sizova; Andrew J Ross; Irina A Ivanova; Vladimir S Borodkin; Michael A J Ferguson; Andrei V Nikolaev
Journal:  ACS Chem Biol       Date:  2011-04-11       Impact factor: 5.100

2.  Differential microbicidal effects of human histone proteins H2A and H2B on Leishmania promastigotes and amastigotes.

Authors:  Yingwei Wang; Yang Chen; Lijun Xin; Stephen M Beverley; Eric D Carlsen; Vsevolod Popov; Kwang-Poo Chang; Ming Wang; Lynn Soong
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

3.  Deletion of UDP-glucose pyrophosphorylase reveals a UDP-glucose independent UDP-galactose salvage pathway in Leishmania major.

Authors:  Anne-Christin Lamerz; Sebastian Damerow; Barbara Kleczka; Martin Wiese; Ger van Zandbergen; Jens Lamerz; Alexander Wenzel; Fong-Fu Hsu; John Turk; Stephen M Beverley; Françoise H Routier
Journal:  Glycobiology       Date:  2010-03-24       Impact factor: 4.313

4.  Leishmania inhibitor of serine peptidase 2 prevents TLR4 activation by neutrophil elastase promoting parasite survival in murine macrophages.

Authors:  Marilia S Faria; Flavia C G Reis; Ricardo L Azevedo-Pereira; Lesley S Morrison; Jeremy C Mottram; Ana Paula C A Lima
Journal:  J Immunol       Date:  2010-11-22       Impact factor: 5.422

5.  Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.

Authors:  Shraddha Kumari; Mukesh Samant; Prashant Khare; Pragya Misra; Sujoy Dutta; Bala Krishna Kolli; Sharad Sharma; Kwang Poo Chang; Anuradha Dube
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

Review 6.  Toll-like receptors and leishmaniasis.

Authors:  Felipe F Tuon; Valdir S Amato; Hélio A Bacha; Tariq Almusawi; Maria I Duarte; Vicente Amato Neto
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

7.  Immunization with persistent attenuated Delta lpg2 Leishmania major parasites requires adjuvant to provide protective immunity in C57BL/6 mice.

Authors:  Chahnaz Kébaïer; Jude E Uzonna; Stephen M Beverley; Phillip Scott
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 8.  Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies.

Authors:  Ifeoma Okwor; Jude Uzonna
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

9.  Proteophosphoglycan confers resistance of Leishmania major to midgut digestive enzymes induced by blood feeding in vector sand flies.

Authors:  Nagila Secundino; Nicola Kimblin; Nathan C Peters; Phillip Lawyer; Althea A Capul; Stephen M Beverley; Salvatore J Turco; David Sacks
Journal:  Cell Microbiol       Date:  2010-01-20       Impact factor: 3.715

10.  DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.

Authors:  Gannavaram Sreenivas; B V Subba Raju; Ruchi Singh; Angamuthu Selvapandiyan; Robert Duncan; Dwijen Sarkar; Hira L Nakhasi; Poonam Salotra
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.